Tug of War: Blood Management Safety (Video)
World's Largest Resource for Cardiovascular Perfusion
Background: Since 1994 at the authors’ institution, approximately 9000 cardiac surgical procedures were performed using activated clotting time (ACT)-monitored heparin anticoagulation for […]
A “convalescent COVID-19” patient with “first hit” at primary infection, encountering a “second hit” of surgery and perioperative insults, might have a hyperimmune response. This “second hit” hypothesis should be considered when COVID-19 convalescent (COVID-19 symptomatic or asymptomatic) patients undergo cardiac surgery and present with unusual complicatio
There has been growing recognition of the favorable and unfavorable hemodynamic effects of this therapy and recent interest in the use of other percutaneous circulatory support devices to offset some of the potentially harmful hemodynamic effects.